Insulet Corp
NASDAQ:PODD
Insulet Corp
Income from Continuing Operations
Insulet Corp
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Insulet Corp
NASDAQ:PODD
|
Income from Continuing Operations
$234m
|
CAGR 3-Years
197%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
4%
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Insulet Corp's Income from Continuing Operations?
Income from Continuing Operations
234m
USD
Based on the financial report for Mar 31, 2024, Insulet Corp's Income from Continuing Operations amounts to 234m USD.
What is Insulet Corp's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
75%
Over the last year, the Income from Continuing Operations growth was 38 900%. The average annual Income from Continuing Operations growth rates for Insulet Corp have been 197% over the past three years , 75% over the past five years .